PRRT2 and colonic neoplasm: As inflammatory signaling is a key driver of colon cancer, particularly regarding colitis-associated cancer [40], this observation suggests that it would be worthwhile to explore the role of the M3R-PKC-p38 MAPK axis in inflammation-associated colon cancer.